High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 3, 2014, Pages 290-295

  Ye, Honghua ^a   He, Fuwei ^a   Fei, Xiaohong ^a   Lou, Yanru ^a   Wang, Shiqi ^a   Yang, Rui ^a   Hu, Yewen ^a   Chen, Xiaomin ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

arthrosclerosis; endothelial progenitor cells; percutaneous coronary intervention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; TROPONIN I; VASCULOTROPIN RECEPTOR 2; AUTACOID; HEPTANOIC ACID DERIVATIVE; LEUKOCYTE ANTIGEN; PYRROLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD LEVEL; CELL COUNT; CLINICAL ARTICLE; CONTROL GROUP; DISEASE MARKER; DRUG MEGADOSE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; JOINT STIFFNESS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY; WORLD HEALTH ORGANIZATION; ANGINA PECTORIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA PECTORIS; ANTIGENS, CD; C-REACTIVE PROTEIN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HEPTANOIC ACIDS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PYRROLES; TROPONIN I;

EID: 84898968642     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413513500     Document Type: Article

References (18)

1. Pelliccia F, Pasceri V, Rosano G, et al. Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention. Circ J. 2013 ; 77 (7). 1728-1735
2. Wojakowski W, Pyrlik A, Krol M, et al. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol. 2013 ; 61 (3). 301-311
3. Van Craenenbroeck EM, Denollet J, Paelinck BP, et al. Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. Clin Sci (Lond). 2009 ; 117 (4). 165-172
4. Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis. 2003 ; 169 (2). 283-291
5. Paajarvi G, Roudier E, Crisby M, Hogberg J, Stenius U. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. FASEB J. 2005 ; 19 (3). 476-478
6. Pollack CV, Hollander JE, Chen AY, et al. Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines CRUSADE initiative. Crit Pathw Cardiol. 2009 ; 8 (1). 29-33
7. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M. Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci. 2004 ; 75 (11). 1287-1302
8. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004 ; 110 (6). 674-678
9. Nomenclature and criteria for diagnosis of ischemic heart disease. report of the joint international society and federation of cardiology/world health organization task force on standardization of clinical nomenclature. Circulation. 1979 ; 59 (3). 607-609
10. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 ; 60 (16). 1581-1598
11. Ye J, Ni P, Kang L, Xu B. Apelin and vascular endothelial growth factor are associated with mobilization of endothelial progenitor cells after acute myocardial infarction. J Biomed Res. 2012 ; 26 (6). 400-409
12. Padfield GJ, Tura-Ceide O, Freyer E, et al. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart. 2013 ; 99 (11). 791-798
13. Scacciatella P, D'Amico M, Pennone M, et al. Effects of EPC capture stent and cd34+ mobilization in acute myocardial infarction. Minerva Cardioangiol. 2013 ; 61 (2). 211-219
14. Scalone G, De Caterina A, Leone AM, et al. Effect of exercise on circulating endothelial progenitor cells in microvascular angina. Circ J. 2013 ; 77 (7). 1777-1782
15. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial. J Am Coll Cardiol. 2009 ; 54 (6). 558-565
16. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001 ; 103 (24). 2885-2890
17. Hristov M, Fach C, Becker C, et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis. 2007 ; 192 (2). 413-420
18. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006 ; 24 (4). 857-864